Form 8-K - Current report:
SEC Accession No. 0001140361-22-034013
Filing Date
2022-09-20
Accepted
2022-09-20 16:30:58
Documents
13
Period of Report
2022-09-14
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K brhc10042019_8k.htm   iXBRL 8-K 40367
2 EXHIBIT 3.1 brhc10042019_ex3-1.htm EX-3.1 111714
  Complete submission text file 0001140361-22-034013.txt   319021

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA bcpc-20220914.xsd EX-101.SCH 3862
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE bcpc-20220914_lab.xml EX-101.LAB 23291
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE bcpc-20220914_pre.xml EX-101.PRE 16550
7 EXTRACTED XBRL INSTANCE DOCUMENT brhc10042019_8k_htm.xml XML 4225
Mailing Address 52 SUNRISE PARK ROAD NEW HAMPTON NY 10958
Business Address 52 SUNRISE PARK ROAD NEW HAMPTON NY 10958 (845) 326-5600
BALCHEM CORP (Filer) CIK: 0000009326 (see all company filings)

EIN.: 132578432 | State of Incorp.: MD | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-13648 | Film No.: 221254055
SIC: 2800 Chemicals & Allied Products